LECAP Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$656K Sell
7,600
-6,853
-47% -$604K 0.31% 135
2026
Q2
$1.13M Buy
+14,453
New +$1.17M 0.48% 74
2024
Q2
– Sell
-11,806
Closed -$1.03M – 375
2024
Q1
$1.03M Buy
+11,806
New +$1.01M 0.21% 172

Other funds holding MDT

LECAP Asset Management's MDT Position: Q3 2026 in Review

LECAP Asset Management reduced its Medtronic (MDT) stake by 47% in Q3 2026, selling an estimated $604K and leaving 7,600 shares worth $656K. The position accounts for 0.31% of the portfolio, ranked #135.

LECAP Asset Management first reported a position in MDT in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.13M in Q2 2026. 1,224 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • LECAP Asset Management held 7,600 shares of Medtronic worth $656K as of Q3 2026.
  • LECAP Asset Management sold 6,853 Medtronic shares in Q3 2026, an estimated $604K.
  • Medtronic made up 0.31% of LECAP Asset Management's portfolio in Q3 2026, its #135 holding.
  • LECAP Asset Management first reported a position in Medtronic in Q1 2024 and has held it in 3 quarters since.
  • LECAP Asset Management's Medtronic position peaked at $1.13M in Q2 2026.
  • 1,224 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on LECAP Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.